Comcast Corporation (NASDAQ: CMCSA, CMCSK), a leading cable,
entertainment and communications company, announced today that it
increased its dividend by 11.1% to $1.00 per share on an annualized
Service Providers Can Leverage Full Spectrum of Deployment Options to Accelerate mVAS Delivery, Reduce Total Cost of Ownership
Comverse has developed a multi-VAS (multi value added services) solution available via the Amazon Web Services (AWS) cloud.
TheGrantLawFirm, PLLC is investigating a potential action on behalf of
United Parcel Service, Inc. (“UPS” or the “Company”) for possible
breaches of fiduciary duty by the Company’s officers and directors,
relating to UPS’s purported failure to comply with federal and state
Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical
company, today announced that Maxine Gowen, Ph.D., its president and
chief executive officer, will present a company overview at the Cowen
and Company 35 th Annual Health Care Conference on Tuesday,
March 3, 2015 at 10:40 a.m. EST in Boston.
Transaction Adds Phase 3-Ready Rare GI Disease Product to Strong Pipeline LEXINGTON, Massachusetts and SAN DIEGO , February 24, 2015 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPG) and Meritage Pharma, Inc. announced today that Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.
Steve Madden (Nasdaq:SHOO), a leading designer and marketer of fashion
footwear and accessories for women, men and children, today announced
financial results for the fourth quarter and full year ended December
31, 2014 and provided initial fiscal year 2015 sales and EPS guidance.
IHS Inc. (NYSE: IHS), the leading global source of critical information
and insight, is reaffirming its 2015 revenue, Adjusted EBITDA (Earnings
Before Interest, Taxes, Depreciation and Amortization) and Adjusted EPS
(earnings per diluted share) guidance.
Second Sight Medical Products, Inc. (Nasdaq:EYES) (“Second Sight” or
“the Company”), a developer, manufacturer and marketer of implantable
visual prosthetics to provide functional vision to blind patients, today
announced that all three of the centers approved to implant the Argus II
Retinal Prosthesis System (“Argus II”) under the French Government
national healthcare reimbursement program entitled ‘Forfait Innovation’
have successfully completed their first implants in patients with
retinitis pigmentosa (RP). Current French implant centers are located in
Paris, Bordeaux, and Strasbourg.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.